“The expansion project was elaborated with due care in order to reduce set-up in fermentation and to optimize the use of other industrial assets, therefore, increasing our production capacity of the Bioenhance line,” says César Martins, Biorigin’s global operations manager

Officials note that Biorigin has spent approximately US$200 million for three major capital projects (involving two in Brazil and one in Louisville) during the past 15 years. The company has been active in the United States for many years but made its first major US facility investment in Louisville back in 2008.

Biorigin’s General Manager Mario Steinmetz adds, “These expansion initiatives were stimulated by the positive perspectives of the market, as well as by the trends related to health and well-being, which lead to [consumers’] increasing search for natural ingredients [and those that are] clean label and Non-GMO.”

About Biorigin

Biorigin is dedicated to the art of creating and producing innovative natural ingredients for the health and well-being of people and animals. Committed to adding value to its customers’ products, it ensures traceability, sustainability, and quality throughout the production process, from the raw material sugarcane to the finished products. It is the first company to obtain the Bonsucro Chain of Custody certification for yeast extracts and derivatives produced from fermentable sugar and sugarcane yeast cream, demonstrating Biorigin’s commitment to social, environmental, and economic practices through sustainable sourcing

Visit www.biorigin.net for more details.